Menu

Chimeric Pancreas Treats Diabetes in Mice

Researchers produce functional organs composed of both mouse and rat cells.

Jan 26, 2017
Tracy Vence

WIKIMEDIA, JAKOB SUCKALEBy injecting murine pluripotent stem cells into specialized rat blastocysts, scientists at the University of Toyko generated a functional mouse-rat chimeric pancreas, according to a study published this week (January 25) in Nature. Transplanted into a mouse that had been engineered to model diabetes, the chimeric pancreas maintained the rodent’s blood-glucose levels for more than a year.  “This is the first time this kind of inter-species organ generation has successfully treated a medical condition,” New Scientist reported.

“There are not that many ways to generate a functional adult human organ for transplantation that can save many people’s lives,” Qiao Zhou of the Harvard Stem Cell Institute who was not involved in the study told The Verge. “This is one I think actually I can see work in the future.”

While researchers have their sights set on generating other chimeric organs, ethical challenges remain. “The biological issues and the ethical issues are still in very preliminary phase,” Timo Otonkoski of the University of Helsinki in Finland told The Verge. “It’s still very hard to know if this has any real potential for human medicine. But it’s interesting biology and it’s interesting to explore whether these possibilities are real or not.”

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.